# Giant Cell Arteritis: Comparison Between Two Standardized Corticosteroids Tapering

> **NCT04012905** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University Hospital, Caen** · enrollment: 150 (estimated)

## Conditions studied

- Giant Cell Arteritis

## Interventions

- **DRUG:** Corticosteroids for Systemic Use

## Key facts

- **NCT ID:** NCT04012905
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2020-11-05
- **Primary completion:** 2023-11
- **Final completion:** 2027-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2020-10-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04012905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04012905, "Giant Cell Arteritis: Comparison Between Two Standardized Corticosteroids Tapering". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04012905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*